Our health insight that you must read
Tenagril is a migraine prophylactic treatment formulated with Feverfew (Tanacetum parthenium), a powerful herb known for its ability to help reduce migraine frequency and severity. By targeting inflammation and vascular health, Tenagril offers long-term support for individuals struggling with migraines.
The SALOME™ range of products provides solutions for previously unmet or poorly met medical needs such as women’s health, tackling issues such as infertility in women with polycystic ovary syndrome…
The 2nd of November is known as World Fertility Day, which strikes a chord with more people than one would expect. After all, the unfortunate reality is that approximately one in six couples in Africa are being affected by infertility, which equates to about 8 million people in Southern Africa alone; and Polycystic Ovary Syndrome (PCOS) also affects 8 – 13% of women. So if it’s so common – along with other women’s health issues like Menorrhagia (heavy menstrual bleeding – HMB), Dysmenorrhea (menstrual pain) – why are these topics still so rarely spoken about?
It seems only fitting that leading up to World Health Day on 07 April 2021, one of South Africa’s most exciting and dynamic pharmaceutical companies announces their formidable new CEO.
Boitumelo Sebambo, has officially taken over the reins from Walter Mbatha and plans to not only continue his legacy of positioning the business as experts in herbal based and natural medicinal products, but this accomplished businesswoman also has aspirations in her new role to put African traditional medicine on the global map.
Sebambo has risen through the ranks, having first joined 3Sixty Global Solutions in 2019 when it was still known as 3Sixty Financial Solutions.
The OTC division of Adcock Ingram has assumed responsibility for the distribution and sales of 3Sixty Biopharmaceuticals’ products. Adcock Ingram OTC is contracted to sell and distribute 3Sixty’s women’s reproductive health products, under the brand name Salome and Tenagril, which helps with migraine symptoms.
March 2022 marks the official commencement of a collaboration between 3Sixty Biopharmaceuticals and Adcock lngram’s OTC division. As a result of this collaboration, Adcock Ingram OTC will take over the sales and distribution of 3Sixly Biopharmaceuticai’s products.
